References
Wang J, Kang Z (2012) Summary of prognostic factors for choroidal neovascularization due to pathological myopia treated by intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol 250:1717–1723
Ruiz-Moreno JM, Montero JA (2003) Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularization in highly myopic eyes. Br J Ophthalmol 87:856–859
Hirata A, Negi A (1998) Lacquer crack lesions in experimental chick myopia. Graefes Arch Clin Exp Ophthalmol 236:138–145
Curtin BJ, Karlin DB (1971) Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol 1:42–53
Kwak N, Okamoto N, Wood JM (2000) VEGF is major stimulator in model of choroidal neovascularization. Investig Ophthalmol Vis Sci 41:3158–3164
Shin YJ, Nam WH, Park SE, Kim JH, Kim HK (2012) Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients. Mol Vis 18:2265–2270
Vongphanit R, Mitchell P, Wang JJ (2002) Prevalence and progression of myopic retinopathy in an older population. Ophthalmology 109:704–711
Stefansson E (2006) Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 51:364–380
D’Amore PA (1994) Mechanisms of retinal and choroidal neovascularization. Investig Ophthalmol Vis Sci 35:3974–3979
Competing interests
All authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, ZY., Zhang, XR. & Chu, RY. Effect of axial length on myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 251, 2269–2270 (2013). https://doi.org/10.1007/s00417-012-2250-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-2250-y